Business Description
GRAIL Inc
NAICS : 541380
SIC : 2835
ISIN : US3847471014
Total Employee Number:
910Compare
Compare
Traded in other countries / regions
GRAL.USANL0.GermanyGRAL.Mexico Index Membership
Russell 2000Russell 3000Russell 1000 IPO Date
2024-06-12Description
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 16.13 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.13 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.09 | |||||
Beneish M-Score | -2.19 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 30.8 | |||||
3-Year EBITDA Growth Rate | 18.4 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 24.3 | |||||
3-Year Book Growth Rate | -24.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 2.64 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 24.86 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.18 | |||||
9-Day RSI | 63.04 | |||||
14-Day RSI | 61.3 | |||||
3-1 Month Momentum % | 28.4 | |||||
6-1 Month Momentum % | -41.47 | |||||
12-1 Month Momentum % | 35.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.74 | |||||
Quick Ratio | 11.51 | |||||
Cash Ratio | 11.02 | |||||
Days Inventory | 30.85 | |||||
Days Sales Outstanding | 42.34 | |||||
Days Payable | 7.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.1 | |||||
Shareholder Yield % | 0.42 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -36.48 | |||||
Operating Margin % | -330.72 | |||||
Net Margin % | -253.22 | |||||
EBITDA Margin % | -255.74 | |||||
FCF Margin % | -187.25 | |||||
OCF Margin % | -186.38 | |||||
ROE % | -16.41 | |||||
ROA % | -14.24 | |||||
ROIC % | -19.29 | |||||
3-Year ROIIC % | -12.1 | |||||
ROC (Joel Greenblatt) % | -461.65 | |||||
ROCE % | -19.12 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 17.7 | |||||
PB Ratio | 1.18 | |||||
Price-to-Tangible-Book | 4.32 | |||||
EV-to-EBIT | -4.49 | |||||
EV-to-Forward-EBIT | -4.66 | |||||
EV-to-EBITDA | -5.81 | |||||
EV-to-Revenue | 14.85 | |||||
EV-to-Forward-Revenue | 14.11 | |||||
EV-to-FCF | -7.93 | |||||
| Price-to-Net-Current-Asset-Value | 5.15 | |||||
| Price-to-Net-Cash | 5.69 | |||||
Earnings Yield (Greenblatt) % | -22.27 | |||||
FCF Yield % | -9.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GRAL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GRAIL Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 156.12 | ||
| EPS (TTM) ($) | -10.37 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 124.38 | ||
| 14-Day RSI | 61.3 | ||
| 14-Day ATR ($) | 4.406321 | ||
| 20-Day SMA ($) | 65.5565 | ||
| 12-1 Month Momentum % | 35.03 | ||
| 52-Week Range ($) | 29.95 - 118.84 | ||
| Shares Outstanding (Mil) | 42.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GRAIL Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GRAIL Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-12 16:30 | In 125 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 124 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-12 16:30 | In 33 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 32 days | ||
| General meeting for 2026 | 2026-06-18 16:00 | 59.45 (+1.87%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-09 11:20 | 61.52 (+1.52%) | ||
| Guidance call for 2026 | 2026-06-03 07:35 | 59.90 (-6.41%) | ||
| Guidance call for 2026 | 2026-05-12 08:40 | 61.26 (-0.26%) | ||
| First quarter earnings conference call for 2026 | 2026-05-05 16:30 | 55.66 (+3.46%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 55.66 (+3.46%) |
Show
Entries
GRAIL Inc Frequently Asked Questions
What is GRAIL Inc(GRAL)'s stock price today?
The current price of GRAL is $72.00. The 52 week high of GRAL is $118.84 and 52 week low is $29.95.
When is next earnings date of GRAIL Inc(GRAL)?
The next earnings date of GRAIL Inc(GRAL) is 2026-08-12 Est..
Does GRAIL Inc(GRAL) pay dividends? If so, how much?
GRAIL Inc(GRAL) does not pay dividend.
Guru Commentaries on NAS:GRAL
No articles.
Press Release
Articles on GRAIL Inc
Headlines
See More- 1
Jun 16, 2026
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GRAIL, Inc. and Encourages Investors to Contact the Firm
Benzinga • 5:09pm
Jun 15, 2026
$GRAL Shareholder News: GRAIL Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law about the Ongoing Securities Class Action
Benzinga • 5:37am
Jun 13, 2026
GRAL INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Benzinga • 8:00pm
Jun 12, 2026
GRAL INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
Benzinga • 9:35am
Jun 11, 2026
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers